DIFFERENTIAL TIME COURSE OF INDUCTION OF 1α,25-DIHYDROXYVITAMIN D3-24-HYDROXYLASE mRNA EXPRESSION IN RATS BY 1α,25-DIHYDROXYVITAMIN D3 AND ITS ANALOGS

This publication has 16 references indexed in Scilit:

• A novel synthetic vitamin D analogue, 2?-(3-hydroxypropoxy)1?, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats
  Calcified Tissue International, 1994
• Expression of 25‐hydroxyvitamin D 24‐hydroxylase cytochrome P450 in kidney and intestine Effect of 1,25‐dihydroxyvitamin D and age
  FEBS Letters, 1991
• On the Mechanisms for the Selective Action of Vitamin D Analogs*
  Endocrinology, 1991
• Cloning and expression of cDNA encoding 25‐hydroxyvitamin D₃ 24‐hydroxylase
  FEBS Letters, 1991
• Regulatory activities of 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism
  Biochemical and Biophysical Research Communications, 1989
• The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
  Journal of Clinical Investigation, 1989
• Protein-binding properties of 22-oxa-1.ALPHA.,25-dihydroxyvitamin D3, a synthetic analogue of 1.ALPHA.,25-dyhydroxyvitamin D3.
  Journal of Nutritional Science and Vitaminology, 1989
• Synthetic analogues of vitamin D₃ with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemia
  FEBS Letters, 1987
• 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.
  Journal of Clinical Investigation, 1984
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.
  Proceedings of the National Academy of Sciences, 1981